A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma
Clinical trial NCT04007198 · COMPLETED
Trial details
- NCT number
- NCT04007198
- Sponsor
- Biocon Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2021-10-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.